Serum 25-hydroxyvitamin D stability: a guide to sample integrity
A common pre-analytical myth says that a vitamin D blood sample begins to fail as soon as it leaves the patient’s arm: spin it immediately, keep it dark, freeze it at once, and never thaw it twice. The actual evidence is less theatrical.
Circulating 25-hydroxyvitamin D, or 25(OH)D, is notably stable under several ordinary handling conditions—including room-temperature exposure and repeated freeze-thaw cycles.
That does not make sample handling irrelevant. It means the real task is to distinguish analyte stability from the rest of the laboratory process. A stable molecule cannot rescue a mislabeled tube, an unsuitable assay, or inconsistent collection procedures. For researchers and laboratories, understanding serum 25-hydroxyvitamin D stability in blood samples is a way to avoid both needless alarm and false confidence.
Why 25(OH)D is a robust marker
Vitamin D status is usually assessed by measuring 25(OH)D in serum. This is not the active hormone, but it is the main circulating form used to estimate vitamin D stores. Its half-life in blood is about 20 days—long enough to make it more informative about overall status than a brief snapshot of active vitamin D metabolism.
The molecule also travels largely bound to vitamin D-binding protein. That binding contributes to its persistence in circulation and helps explain why 25(OH)D does not behave like a fragile analyte that disappears when a tube sits on a bench for an afternoon. Stability has been observed in serum and in unprocessed whole blood, including during room-temperature exposure.
The distinction matters because laboratory handling advice is sometimes borrowed wholesale from other analytes. Some compounds are highly vulnerable to light, heat, or delays before separation. Applying those rules automatically to 25(OH)D may create extra work without improving the result. Conversely, calling the analyte stable does not mean every sample, instrument, and storage history is interchangeable.
Stability is a property of the analyte under defined conditions—not a promise that every step in the testing process is error-proof.
For vitamin D testing, the practical question is not whether 25(OH)D is indestructible. It is how far a sample can travel through collection, transport, processing, and storage before the conditions exceed what has been studied or validated.
What delays mean for whole blood and serum
A delay between collection and centrifugation often sounds like an obvious threat to sample integrity. For 25(OH)D, the available evidence is reassuring: in unprocessed whole blood, 25(OH)D₃ bound to vitamin D-binding protein has remained stable at room temperature for up to three days. Delaying centrifugation for as long as 72 hours has also produced changes smaller than the precision limits of the analytical assay.
That finding is useful for field studies, multicentre research, and routine transport where immediate processing is not realistic. It does not mean that three days should become a universal target. A study comparing small changes in vitamin D status may need tighter, more consistent procedures than a routine clinical service. And a finding about 25(OH)D does not automatically validate delayed processing for other tests ordered from the same tube.
Once serum has been separated, refrigeration at 2–8 °C is a practical short-term option; reported stability under refrigeration is about four to seven days. For longer storage, frozen serum at temperatures from −20 °C to −70 °C has remained stable for years before analysis. The exact choice should still match the laboratory’s validated method and the study’s collection protocol.
A useful way to think about the main handling conditions:
| Sample condition | What the evidence supports | Practical interpretation |
|---|---|---|
| Whole blood at room temperature | Stability for up to three days; delayed centrifugation up to 72 hours has shown changes below assay precision limits | Immediate centrifugation is not automatically necessary for 25(OH)D, but document and standardize delays |
| Serum at room temperature | Stability for up to 24 hours has been reported, including exposure to fluorescent and ultraviolet light | Brief routine exposure is not a reason to reject a sample |
| Refrigerated serum, 2–8 °C | Stability for roughly four to seven days | Useful for short-term storage; follow the laboratory’s validated interval |
| Frozen serum, −20 °C to −70 °C | Stability for years has been reported | Appropriate for longer-term storage when the protocol and assay are consistent |
| Freeze-thaw cycles | Reliable results have been maintained through up to four cycles | Avoid unnecessary cycling, but do not treat one thaw as automatic sample failure |
These are evidence-based guideposts, not a substitute for a laboratory’s own validation. Storage duration, assay platform, sample matrix, and the purpose of the measurement all shape what a defensible protocol looks like.
Freeze-thaw cycles: not a biochemical cliff
The idea that a single freeze-thaw cycle invalidates a vitamin D result is a particularly durable myth. Available evidence indicates that serum 25(OH)D is unaffected by up to four freeze-thaw cycles, with reliable assay results maintained. That is a meaningful degree of resilience for archived samples and studies in which aliquoting cannot be perfectly choreographed.
Still, resilience is not an invitation to thaw and refreeze samples without tracking the history. Repeated handling can introduce avoidable variation, and the evidence does not define a universal failure point across every automated immunoassay and LC-MS/MS platform. The upper limit at which degradation might occur across platforms remains uncertain. If a project depends on small differences between groups or time points, a consistent aliquoting plan is more defensible than leaning on the maximum demonstrated tolerance.
For long-term storage, aliquots reduce the need to thaw the entire specimen each time. That is good sample management even when the analyte itself is robust. Record storage temperature and thaw history, and use the same procedures for comparison groups. Otherwise, a study can turn a manageable pre-analytical variable into a systematic difference between samples.
There is also a difference between an analyte surviving storage and every assay producing identical numbers. Immunoassays and LC-MS/MS methods can differ in calibration, specificity, and susceptibility to matrix effects. A stable sample may therefore yield results that vary by method—not because 25(OH)D decomposed in the freezer, but because measurement is not the same thing as storage.
Light, hemolysis, and the limits of the evidence
Light protection is often treated as a reflex in sample handling. For 25(OH)D, the evidence does not support claims that the analyte degrades immediately at room temperature or must be shielded from light as soon as blood is drawn. Serum 25(OH)D has remained stable for 24 hours at room temperature under both fluorescent and ultraviolet light exposure.
That is not a reason to expose samples deliberately or to ignore a laboratory’s standard procedures. It is a reason to avoid rejecting a specimen—or adding complicated handling steps—based on an exaggerated claim about light sensitivity. Protocols should respond to demonstrated risks, not to the general aura of fragility that sometimes surrounds laboratory samples.
Hemolysis calls for more restraint. The impact of severe hemolysis on 25(OH)D measurement is not established by the available evidence here, and neither is the effect of gross bacterial contamination. It would be overconfident to declare that hemolysis has no effect, just as it would be wrong to claim that any visible hemolysis necessarily invalidates the result. The sensible route is to follow the assay manufacturer’s interference data and the laboratory’s rejection or qualification criteria.
This is where a phrase such as “sample stability” can mislead. It refers to whether the measured analyte remains sufficiently unchanged under specified conditions. It does not answer every question about interference, contamination, tube type, or the performance of a particular instrument. Stability is one part of pre-analytical quality, not a universal certificate of sample fitness.
Standardizing collection for meaningful comparisons
For a single clinical result, modest handling variation may be smaller than assay imprecision. In a clinical trial, a fortification study, or a population survey, inconsistent handling can become more consequential—especially when the expected change in serum 25(OH)D is small. The point of standardization is not to impose dramatic precautions. It is to ensure that differences between samples reflect biology or intervention rather than different routes from collection to analysis.
A practical protocol should make these decisions explicit:
1. Define the collection and processing window. State how long whole blood may remain unprocessed, and use the same rule across sites and study groups. Evidence supports stability up to 72 hours at room temperature, but a study may choose a shorter operational window for consistency.
2. Specify storage conditions and duration. Distinguish short-term refrigeration from long-term frozen storage. Record the temperature range rather than relying on vague labels such as “cold” or “frozen.”
3. Plan aliquots before archiving. If samples will be tested in batches, aliquoting can limit repeated thawing. The evidence supports stability through four cycles, but minimizing avoidable cycles is still sound practice.
4. Document the assay platform. Method-related variability can persist even when sample integrity is excellent. Comparisons across time or sites are stronger when the analytical method is consistent or when method differences are addressed.
5. Set a policy for visibly compromised samples. Hemolysis and contamination are not covered by the same reassuring stability findings. Use method-specific interference guidance rather than inventing a universal rule.
The same logic applies to blood sample storage for vitamin D analysis in large studies: define the route, apply it consistently, and retain enough metadata to interpret deviations. A protocol that says exactly when centrifugation occurred and how long serum was stored is more useful than one that merely says samples were handled carefully.
The main threat is often not a few hours on the bench. It is an undocumented difference in handling that tracks with the group you are trying to compare.
The laboratory result is more than the molecule
A measured serum 25(OH)D concentration sits at the end of a chain: collection, transport, processing, storage, assay, and interpretation. The molecule’s stability makes that chain more forgiving than some warnings imply, but it does not erase variation introduced elsewhere. Clinical laboratory vitamin D assay variability remains a separate issue from pre-analytical degradation.
This matters especially when results are compared across laboratories or over time. A change in concentration may reflect a real shift in vitamin D status, a change in assay method, or differences in calibration and sample handling. For research, the safest interpretation comes from consistent methods and transparent procedures—not from assuming that a number is self-explanatory because the sample was frozen.
The biochemical verdict is straightforward: serum 25(OH)D is a robust analyte. It tolerates several days at room temperature under studied conditions, refrigeration for several days, long-term frozen storage, and up to four freeze-thaw cycles without demonstrated loss of reliable results. Immediate light shielding and instant centrifugation are not universal requirements for preserving this analyte.
But “robust” is not synonymous with “careless.” Use a consistent protocol, record deviations, and treat assay performance and sample interference as separate questions. The myth is that 25(OH)D is so fragile that routine handling ruins it. The opposite myth—that stability makes handling irrelevant—is no better.